8 research outputs found
Number and proportion of enrolled participants by pathogens detected, overall and by age group, acute febrile illness study, May 7, 2012–May 6, 2015, Puerto Rico.
<p>Number and proportion of enrolled participants by pathogens detected, overall and by age group, acute febrile illness study, May 7, 2012–May 6, 2015, Puerto Rico.</p
Characteristics and clinical features of participants at study enrollment by pathogen detected, acute febrile illness study, May 7, 2012–May 6, 2015, Puerto Rico.
<p>Characteristics and clinical features of participants at study enrollment by pathogen detected, acute febrile illness study, May 7, 2012–May 6, 2015, Puerto Rico.</p
Number of laboratory-positive dengue, chikungunya, influenza and other respiratory viral illness by month of illness onset, acute febrile illness study, May 7, 2012–May 6, 2015, Puerto Rico.
<p>Number of laboratory-positive dengue, chikungunya, influenza and other respiratory viral illness by month of illness onset, acute febrile illness study, May 7, 2012–May 6, 2015, Puerto Rico.</p
Early predictors of laboratory-positive dengue versus all other acute febrile illnesses by age group, acute febrile illness study, May 7, 2012–May 6, 2015, Puerto Rico.
<p>Early predictors of laboratory-positive dengue versus all other acute febrile illnesses by age group, acute febrile illness study, May 7, 2012–May 6, 2015, Puerto Rico.</p
Clinical and epidemiologic characteristics of dengue and other etiologic agents among patients with acute febrile illness, Puerto Rico, 2012–2015
<div><p>Identifying etiologies of acute febrile illnesses (AFI) is challenging due to non-specific presentation and limited availability of diagnostics. Prospective AFI studies provide a methodology to describe the syndrome by age and etiology, findings that can be used to develop case definitions and multiplexed diagnostics to optimize management. We conducted a 3-year prospective AFI study in Puerto Rico. Patients with fever ≤7 days were offered enrollment, and clinical data and specimens were collected at enrollment and upon discharge or follow-up. Blood and oro-nasopharyngeal specimens were tested by RT-PCR and immunodiagnostic methods for infection with dengue viruses (DENV) 1–4, chikungunya virus (CHIKV), influenza A and B viruses (FLU A/B), 12 other respiratory viruses (ORV), enterovirus, <i>Leptospira</i> spp., and <i>Burkholderia pseudomallei</i>. Clinical presentation and laboratory findings of participants infected with DENV were compared to those infected with CHIKV, FLU A/B, and ORV. Clinical predictors of laboratory-positive dengue compared to all other AFI etiologies were determined by age and day post-illness onset (DPO) at presentation. Of 8,996 participants enrolled from May 7, 2012 through May 6, 2015, more than half (54.8%, 4,930) had a pathogen detected. Pathogens most frequently detected were CHIKV (1,635, 18.2%), FLU A/B (1,074, 11.9%), DENV 1–4 (970, 10.8%), and ORV (904, 10.3%). Participants with DENV infection presented later and a higher proportion were hospitalized than those with other diagnoses (46.7% versus 27.3% with ORV, 18.8% with FLU A/B, and 11.2% with CHIKV). Predictors of dengue in participants presenting <3 DPO included leukopenia, thrombocytopenia, headache, eye pain, nausea, and dizziness, while negative predictors were irritability and rhinorrhea. Predictors of dengue in participants presenting 3–5 DPO were leukopenia, thrombocytopenia, facial/neck erythema, nausea, eye pain, signs of poor circulation, and diarrhea; presence of rhinorrhea, cough, and red conjunctiva predicted non-dengue AFI. By enrolling febrile patients at clinical presentation, we identified unbiased predictors of laboratory-positive dengue as compared to other common causes of AFI. These findings can be used to assist in early identification of dengue patients, as well as direct anticipatory guidance and timely initiation of correct clinical management.</p></div
Clinical features of participants at enrollment, acute febrile illness study, May 7, 2012–May 6, 2015, Puerto Rico.
<p>Clinical features of participants at enrollment, acute febrile illness study, May 7, 2012–May 6, 2015, Puerto Rico.</p
Late predictors of laboratory-positive dengue versus all other acute febrile illnesses for all ages, acute febrile illness study, May 7, 2012–May 6, 2015, Puerto Rico<sup>*</sup>.
<p>Late predictors of laboratory-positive dengue versus all other acute febrile illnesses for all ages, acute febrile illness study, May 7, 2012–May 6, 2015, Puerto Rico<sup><a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0005859#t007fn001" target="_blank">*</a></sup>.</p
Characteristics of participants by year of enrollment, acute febrile illness study, May 7, 2012–May 6, 2015, Puerto Rico.
<p>Characteristics of participants by year of enrollment, acute febrile illness study, May 7, 2012–May 6, 2015, Puerto Rico.</p